A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments

The DNA damage response kinase ATR may be a useful cancer therapeutic target. ATR inhibition synergizes with loss of ERCC1, ATM, XRCC1 and DNA damaging chemotherapy agents. Clinical trials have begun using ATR inhibitors in combination with cisplatin. Here we report the first synthetic lethality scr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohni, Kareem N., Thompson, Petria S., Luzwick, Jessica W., Glick, Gloria G., Pendleton, Christopher S., Lehmann, Brian D., Pietenpol, Jennifer A., Cortez, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428765/
https://www.ncbi.nlm.nih.gov/pubmed/25965342
http://dx.doi.org/10.1371/journal.pone.0125482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428765/
https://www.ncbi.nlm.nih.gov/pubmed/25965342
http://dx.doi.org/10.1371/journal.pone.0125482

Ejemplares similares